These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 17059900)

  • 1. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
    Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Risk factors for ulcerative colitis associated colorectal cancers in a Hungarian cohort of ulcerative colitis patients].
    Lakatos L; Mester G; Erdélyi Z; David G; Pandúr T; Balogh M; Fischer S; Vargha P; Lakatos PL
    Orv Hetil; 2006 Jan; 147(4):175-81. PubMed ID: 16515026
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MHC Class II alleles in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Gut; 2009 Sep; 58(9):1226-33. PubMed ID: 19251712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methylation status of genes in non-neoplastic mucosa from patients with ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Sandborn WJ; Bryant SC; Smyrk TC
    Am J Gastroenterol; 2010 Jul; 105(7):1610-9. PubMed ID: 20160714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pericholangitis and sclerosing cholangitis are risk factors for dysplasia and cancer in ulcerative colitis.
    D'Haens GR; Lashner BA; Hanauer SB
    Am J Gastroenterol; 1993 Aug; 88(8):1174-8. PubMed ID: 8338083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does the use of 5-aminosalicylates in inflammatory bowel disease prevent the development of colorectal cancer?
    Bernstein CN; Blanchard JF; Metge C; Yogendran M
    Am J Gastroenterol; 2003 Dec; 98(12):2784-8. PubMed ID: 14687833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are dysplasia and colorectal cancer endoscopically visible in patients with ulcerative colitis?
    Rubin DT; Rothe JA; Hetzel JT; Cohen RD; Hanauer SB
    Gastrointest Endosc; 2007 Jun; 65(7):998-1004. PubMed ID: 17451704
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predictive and protective factors associated with colorectal cancer in ulcerative colitis: A case-control study.
    Velayos FS; Loftus EV; Jess T; Harmsen WS; Bida J; Zinsmeister AR; Tremaine WJ; Sandborn WJ
    Gastroenterology; 2006 Jun; 130(7):1941-9. PubMed ID: 16762617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early onset of ulcerative colitis: long-term follow-up with special reference to colorectal cancer and primary sclerosing cholangitis.
    Lindberg J; Stenling R; Palmqvist R; Rutegård J
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):534-8. PubMed ID: 18493208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ursodeoxycholic acid treatment in IBD-patients with colorectal dysplasia and/or DNA-aneuploidy: a prospective, double-blind, randomized controlled pilot study.
    Sjöqvist U; Tribukait B; Ost A; Einarsson C; Oxelmark L; Löfberg R
    Anticancer Res; 2004; 24(5B):3121-7. PubMed ID: 15510599
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The risk for cancer or dysplasia in ulcerative colitis patients with primary sclerosing cholangitis.
    Shetty K; Rybicki L; Brzezinski A; Carey WD; Lashner BA
    Am J Gastroenterol; 1999 Jun; 94(6):1643-9. PubMed ID: 10364038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical course of ulcerative colitis in patients with and without primary sclerosing cholangitis.
    Moayyeri A; Daryani NE; Bahrami H; Haghpanah B; Nayyer-Habibi A; Sadatsafavi M
    J Gastroenterol Hepatol; 2005 Mar; 20(3):366-70. PubMed ID: 15740478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinicopathological study of colorectal cancer occurring in patients with ulcerative colitis: results from a single hospital in Japan.
    Fujita T; Ando T; Watanabe O; Hasegawa M; Miyake N; Kondo S; Kato T; Ishiguro K; Nakamura M; Miyahara R; Ohmiya N; Niwa Y; Goto H
    Hepatogastroenterology; 2010; 57(99-100):487-92. PubMed ID: 20698214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S; Andersen SN; Aamodt G; Langmark F; Clausen OP; Aadland E; Fausa O; Rydning A; Vatn MH
    Scand J Gastroenterol; 2009; 44(1):46-55. PubMed ID: 18609187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of colorectal cancer in ulcerative colitis in India.
    Venkataraman S; Mohan V; Ramakrishna BS; Peter S; Chacko A; Chandy G; Kurian G; Kurian S; Mathan M; Mathan VI; Patra S; Pulimood A; Rolston DD
    J Gastroenterol Hepatol; 2005 May; 20(5):705-9. PubMed ID: 15853982
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor necrosis factor-alpha polymorphisms in ulcerative colitis-associated colorectal cancer.
    Garrity-Park MM; Loftus EV; Bryant SC; Sandborn WJ; Smyrk TC
    Am J Gastroenterol; 2008 Feb; 103(2):407-15. PubMed ID: 18289203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study.
    Joo M; Abreu-e-Lima P; Farraye F; Smith T; Swaroop P; Gardner L; Lauwers GY; Odze RD
    Am J Surg Pathol; 2009 Jun; 33(6):854-62. PubMed ID: 19295408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Colorectal neoplasia in Crohn's colitis: a retrospective comparative study with ulcerative colitis.
    Svrcek M; Cosnes J; Beaugerie L; Parc R; Bennis M; Tiret E; Fléjou JF
    Histopathology; 2007 Apr; 50(5):574-83. PubMed ID: 17394493
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-aminosalicylate is not chemoprophylactic for colorectal cancer in IBD: a population based study.
    Bernstein CN; Nugent Z; Blanchard JF
    Am J Gastroenterol; 2011 Apr; 106(4):731-6. PubMed ID: 21407180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for colorectal neoplasia in inflammatory bowel disease: a nested case-control study from Copenhagen county, Denmark and Olmsted county, Minnesota.
    Jess T; Loftus EV; Velayos FS; Winther KV; Tremaine WJ; Zinsmeister AR; Scott Harmsen W; Langholz E; Binder V; Munkholm P; Sandborn WJ
    Am J Gastroenterol; 2007 Apr; 102(4):829-36. PubMed ID: 17222314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.